186 related articles for article (PubMed ID: 32099365)
1. Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer.
He W; Xiao W; Zhang X; Sun Y; Chen Y; Chen Q; Fang X; Du S; Sha X
Int J Nanomedicine; 2020; 15():779-793. PubMed ID: 32099365
[TBL] [Abstract][Full Text] [Related]
2. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.
Zhang X; Wu Y; Zhang M; Mao J; Wu Y; Zhang Y; Yao J; Xu C; Guo W; Yu B
Int J Nanomedicine; 2017; 12():8779-8799. PubMed ID: 29263668
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles.
Wang Y; Li Y; Zhang L; Fang X
Arch Pharm Res; 2008 Apr; 31(4):530-8. PubMed ID: 18449513
[TBL] [Abstract][Full Text] [Related]
4. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
Wang YZ; Fang XL; Li YJ; Zhang ZW; Han LM; Sha XY
Yao Xue Xue Bao; 2008 Jun; 43(6):640-6. PubMed ID: 18822969
[TBL] [Abstract][Full Text] [Related]
5. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
6. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
7. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
Tam YT; Gao J; Kwon GS
J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
[TBL] [Abstract][Full Text] [Related]
8. Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel.
Xiong XY; Pan X; Tao L; Cheng F; Li ZL; Gong YC; Li YP
Int J Biol Macromol; 2017 Oct; 103():1011-1018. PubMed ID: 28552723
[TBL] [Abstract][Full Text] [Related]
9. Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.
Shuai Q; Cai Y; Zhao G; Sun X
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182734
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with pluronic P105/poly(caprolactone) copolymers.
Wang Y; Li Y; Wang Q; Fang X
Pharmazie; 2008 Jun; 63(6):446-52. PubMed ID: 18604988
[TBL] [Abstract][Full Text] [Related]
11. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
12. Study on the preparation and activity of intelligent response poly(lactic-co-glycolic acid)-ss-polyethylene glycol copolymer micelles.
Wang S; Xie L; Liu Y; Yang Q; Jia W; Zhao D; Zhao X
J Biomater Appl; 2022 Aug; 37(2):259-274. PubMed ID: 35533369
[TBL] [Abstract][Full Text] [Related]
13. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
Tam YT; Shin DH; Chen KE; Kwon GS
J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
[TBL] [Abstract][Full Text] [Related]
14. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.
Wang Y; Hao J; Li Y; Zhang Z; Sha X; Han L; Fang X
Biomaterials; 2012 Jun; 33(18):4741-51. PubMed ID: 22445254
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105/L101 mixed polymeric micelles.
Wang Y; Li Y; Wang Q; Wu J; Fang X
Yakugaku Zasshi; 2008 Jun; 128(6):941-50. PubMed ID: 18520140
[TBL] [Abstract][Full Text] [Related]
16. A novel mixed polymeric micelle for co-delivery of paclitaxel and retinoic acid and overcoming multidrug resistance: synthesis, characterization, cytotoxicity, and pharmacokinetic evaluation.
Emami J; Rezazadeh M; Mashayekhi M; Rostami M; Jahanian-Najafabadi A
Drug Dev Ind Pharm; 2018 May; 44(5):729-740. PubMed ID: 29235901
[TBL] [Abstract][Full Text] [Related]
17. β-Lapachone and Paclitaxel Combination Micelles with Improved Drug Encapsulation and Therapeutic Synergy as Novel Nanotherapeutics for NQO1-Targeted Cancer Therapy.
Zhang L; Chen Z; Yang K; Liu C; Gao J; Qian F
Mol Pharm; 2015 Nov; 12(11):3999-4010. PubMed ID: 26415823
[TBL] [Abstract][Full Text] [Related]
18. Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers.
Zhang F; Zhang S; Pollack SF; Li R; Gonzalez AM; Fan J; Zou J; Leininger SE; Pavía-Sanders A; Johnson R; Nelson LD; Raymond JE; Elsabahy M; Hughes DM; Lenox MW; Gustafson TP; Wooley KL
J Am Chem Soc; 2015 Feb; 137(5):2056-66. PubMed ID: 25629952
[TBL] [Abstract][Full Text] [Related]
19. RGD peptide-decorated micelles assembled from polymer-paclitaxel conjugates towards gastric cancer therapy.
Shi J; Liu S; Yu Y; He C; Tan L; Shen YM
Colloids Surf B Biointerfaces; 2019 Aug; 180():58-67. PubMed ID: 31028965
[TBL] [Abstract][Full Text] [Related]
20. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
